Pfizer has asked for emergency approval from the US Food and Drug Administration for its COVID-19 vaccine for children ages five to 11, the company said Thursday.
“With new cases in children in the US continuing to be at a high level, this submission is an important step in our ongoing effort againstCOVID19,” the drugmaker wrote on Twitter.
“We’re committed to working with the FDA with the ultimate goal of helping protect children against this serious public health threat.”
The agency has scheduled its panel of advisers to meet and discuss the application on Oct. 26, making it possible that kids could receive the shot shortly after.
Pfizer has said its vaccine, which was created with German partner BioNTech, was proven to